INMB: INmune Bio, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
INmune Bio, Inc. (INMB) savdolarning yo'qligi sababli tashqi moliyalashtirishga tayanib, Altsgeymer kasalligi uchun immunoterapiyalarni ishlab chiqmoqda. Ilmiy jamoa barcha ishlab chiqarish va tadqiqot jarayonlarini autsorsing qilish orqali moslashuvchanlikni saqlaydi. PEG koeffitsiyenti foyda o'sish sur'atlarining baholash dinamikasini namoyish etadi, bunda 0.00 qiymati ushbu darajani xarakterlaydi. 2-fazali sinov natijalariga bo'lgan kutishlar asosiy katalizator vazifasini o'taydi, R&D xarajatlari esa allaqachon narxga kiritilgan.
INmune Bio, Inc. (INMB) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati INmune Bio, Inc.|INMB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi inmunebio.com|INMB - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar INmune Bio Corp|INMB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi INmune Bio|Shoshilinch likvidlik koeffitsiyenti inmunebio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
INMB - Kompaniyaning sof foydasi|Kelajakdagi foyda INmune Bio, Inc.|INMB - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori INmune Bio Corporation|INMB - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati INmune Bio Corp|INMB - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda INmune Bio|INMB - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi inmunebio.com|INMB - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi INmune Bio, Inc.
Kompaniyaning umumiy tahlili:INMB - INmune Bio Inc
INmune Bio, Inc. (INMB) Alzheimer kasalligi terapiyalarini ishlab chiqishga e'tibor qaratadi va hozirda tijorat sotuvlariga ega emas. Foyda o'sishiga nisbatan P/E koeffitsiyentini tahlil qilish joriy aksiya narxi foyda kengayishi sur'ati bilan oqlangan yoki oqlanmaganini aniqlashga yordam beradi. Birga solishtirganda pastroq qiymat odatda aktivning o'sishiga nisbatan qadrsizlanganini anglatadi. Biroq, biotexnologiya startaplari uchun bunday chegirma operatsion xatarlarni ko'rsatishi mumkin. Bu yerda bozor kapitalizatsiyasi joriy daromadlilikdan ko'ra FDA qarorlariga bog'liqdir.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Pharvaris Pharma PHVS|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TRML|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Narx-foyda va o‘sish multiplikatori Pharming Group NV (PHAR)|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|PEG multiplikatori Upstream Pharma (UPB)|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Gossamer Bio - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda KalVista Pharma|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc.) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati RIGL|PEG multiplikatori ANAB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Astria Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|rapt.com (RAPT) - O‘sish sur’atiga tuzatilgan narx-foyda|JBIO: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACRS (aclaristx.com)|KYTX: PEG multiplikatori|TLSA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio, Inc|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VTYX (Ventyx Biosciences, Inc)|PEG multiplikatori THTX|Narx-foyda va o‘sish multiplikatori avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Agenus, Inc. (AGEN)|Climb Bio, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati zurabio.com ZURA|aTyr Pharma, Inc. (ATYR) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ADAG|Narxning foydaga va o‘sish sur’atiga nisbati ImageneBio|Narx-foyda va o‘sish multiplikatori Shattuck Therapeutics (STTK)|PEG multiplikatori EQ|Narxning foydaga va o‘sish sur’atiga nisbati CNTB (connectbiopharm.com)|Narxning foydaga va o‘sish sur’atiga nisbati Immunic IMUX|ATRA (Atara Biotherapeutics, Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|InflaRx GmbH - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XFOR (X4 Pharmaceuticals Inc.)|ACET: PEG multiplikatori|Celularity (CELU) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|Narx-foyda va o‘sish multiplikatori Akari Therapeutics PLC AKTX|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|PEG multiplikatori Q32 Bio Inc QTTB|GOVX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (edesabiotech.com)|IBIO: PEG multiplikatori|CARM - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|Narx-foyda va o‘sish multiplikatori aptevotherapeutics.com APVO|AIM ImmunoTech - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Aditxt Inc. ADTX|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XRTX (XORTX Corp) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|HIND: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revbiosciences.com (REVB)|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|Scinai Immunotherapeutics Ltd (SCNI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|affimed.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS: Narx-foyda va o‘sish multiplikatori|ITOS - PEG multiplikatori|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TCBP|THRD (Third Harmonic Bio) - PEG multiplikatori
